184 related articles for article (PubMed ID: 23604067)
21. Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis.
Heinosalo T; Gabriel M; Kallio L; Adhikari P; Huhtinen K; Laajala TD; Kaikkonen E; Mehmood A; Suvitie P; Kujari H; Aittokallio T; Perheentupa A; Poutanen M
Hum Reprod; 2018 May; 33(5):817-831. PubMed ID: 29462326
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
23. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway.
Huang Y; Zhao K; Hu Y; Zhou Y; Luo X; Li X; Wei L; Li Z; You Q; Guo Q; Lu N
Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984
[TBL] [Abstract][Full Text] [Related]
24. Loss of Sfrp2 contributes to the neurological disorders related with morphine withdrawal via Wnt/β-catenin signaling.
Wang JC; Li YQ; Feng DY; Zhou X; Yan FQ; Li Y; Gao L; Li LH
Behav Brain Res; 2019 Feb; 359():609-618. PubMed ID: 30291843
[TBL] [Abstract][Full Text] [Related]
25. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
26. Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway.
Tang C; Gong L; Lvzi Xu ; Qiu K; Zhang Z; Wan L
Biochem Biophys Res Commun; 2020 May; 526(1):170-175. PubMed ID: 32201078
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.
Yamamura S; Kawakami K; Hirata H; Ueno K; Saini S; Majid S; Dahiya R
Mol Cancer Ther; 2010 Jun; 9(6):1680-7. PubMed ID: 20501806
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
29. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
[TBL] [Abstract][Full Text] [Related]
31. Secreted frizzled-related protein 2 ameliorates diabetic cardiomyopathy by activating mitophagy.
Zheng H; Li W; Huang G; Zhu H; Wen W; Liu X; Sun L; Ma T; Huang X; Hu Y; Huang Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166989. PubMed ID: 38101654
[TBL] [Abstract][Full Text] [Related]
32. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
[TBL] [Abstract][Full Text] [Related]
33. Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma.
Nasarre P; Garcia DI; Siegel JB; Bonilla IV; Mukherjee R; Hilliard E; Chakraborty P; Nasarre C; Yustein JT; Lang M; Jaffa AA; Mehrotra S; Klauber-DeMore N
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070758
[TBL] [Abstract][Full Text] [Related]
34.
Yang E; Ding C; Zhu X; Zhang J; Zhang W; Zhao Y; Zhang J; Lin X
Cardiovasc Diagn Ther; 2023 Jun; 13(3):523-533. PubMed ID: 37405011
[TBL] [Abstract][Full Text] [Related]
35. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
36. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer.
Zhao X; Wang Q; Yang S; Chen C; Li X; Liu J; Zou Z; Cai D
Eur J Pharmacol; 2016 Jun; 781():60-8. PubMed ID: 27041643
[TBL] [Abstract][Full Text] [Related]
37. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.
Xiao Q; Yang Y; Zhang X; An Q
Tumour Biol; 2016 May; 37(5):6315-21. PubMed ID: 26628297
[TBL] [Abstract][Full Text] [Related]
38. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
40. The secreted Frizzled-Related Protein 2 modulates cell fate and the Wnt pathway in the murine intestinal epithelium.
Skah S; Nadjar J; Sirakov M; Plateroti M
Exp Cell Res; 2015 Jan; 330(1):56-65. PubMed ID: 25447442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
